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Abstract
Background: Gastroesophageal reflux disease (GERD) causes a wide range of clinical symptoms
and potentially serious complications, but epidemiological data about GERD in China are limited.
The aim of this pilot study was to develop and validate a methodology for the epidemiological study
of GERD in China.
Methods: Regionally stratified, randomized samples of Shanghai residents (n = 919) completed
Mandarin translations of the Reflux Disease Questionnaire (RDQ), GERD Impact Scale, Quality of
Life in Reflux and Dyspepsia (QOLRAD) questionnaire and 36-item Short Form Health Survey (SF-
36). Reliability and construct validity were tested by appropriate statistical analyses.
Results: The response rate was 86%. The test-retest reliability coefficients for the RDQ, GERD
Impact Scale, QOLRAD and SF-36 were 0.80, 0.71, 0.93 and 0.96, respectively, and Cronbach's
alpha coefficients were 0.86, 0.80, 0.98 and 0.90, respectively. Dimension scores were highly
correlated with the total scores for the QOLRAD and SF-36, and factor analysis showed credible
construct validity for the RDQ, GERD Impact Scale and SF-36. The RDQ GERD score was
significantly negatively correlated with QOLRAD dimensions of food and drink problems and social
functioning, and was significantly negatively correlated with all dimensions of the SF-36. All eight of
the SF-36 dimensions were significantly correlated with the QOLRAD total score.
Conclusion:  This study developed and tested a successful survey methodology for the
investigation of GERD in China. The questionnaires used demonstrated credible reliability and
construct validity, supporting their use in larger epidemiological surveys of GERD in China.
Background
Gastroesophageal reflux disease (GERD) is a common dis-
order caused by backflow of stomach contents into the
esophagus. As it can cause a wide range of clinical symp-
toms and potentially serious complications, the epidemi-
ology of GERD has been a subject of much interest in
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recent years. GERD is frequently diagnosed on the basis of
symptoms alone, with the criterion for diagnosis in clini-
cal practice being when reflux symptoms become trouble-
some to the patient [1]. However, for epidemiological
studies, a simple symptom threshold is required to iden-
tify those who have GERD. In many studies, this threshold
is defined as at least weekly reflux symptoms [2]. GERD is
common in the West, with a prevalence of about 10–20%,
but the prevalence in Asia is generally lower at approxi-
mately 5% [2]. The prevalence of GERD is, however,
thought to be increasing [3], with trends in Asia attracting
particular interest [4]. There have been few high quality,
population-based epidemiological surveys of GERD in
Asia, particularly in China [5]. A number of methodolog-
ical challenges associated with studying the epidemiology
of GERD in this region may have contributed to this pau-
city.
To identify reflux symptoms accurately, validated patient-
completed questionnaires are needed, as clinicians tend
to underestimate the presence and severity of reflux symp-
toms reported by patients [6]. In particular, validated
symptom descriptors (e.g. 'burning behind the breast-
bone') are necessary because terms such as 'heartburn' are
known to be poorly understood by patients [7]; this is of
particular relevance to Chinese populations, because
there is no word for 'heartburn' in Mandarin Chinese
beyond specialist medical circles, and a survey in the USA
revealed that only 13.2% of East Asian patients under-
stood the term [7].
Within the Chinese population, language and cultural dif-
ferences can lead to different communities perceiving and
expressing their symptoms differently. In China, Manda-
rin is the official language, but about half the population
does not speak it, particularly those living in rural areas
and older people [8]. There are thousands of local dia-
lects, many of which are mutually unintelligible when
spoken. All use the same writing system, and overall liter-
acy rates in China are high, but literacy among older peo-
ple, women and those living in rural areas is relatively
low; in the 2003 census, over 9.6% of women and 2.1%
of men were illiterate or semi-literate [9].
Population surveys can be difficult to implement in
China. Telephone surveys may introduce population bias
in favour of the more wealthy urban Chinese population
who are more likely to have telephones. The utility of
postal surveys is limited by the ability of the respondent
to understand the terms used [10] which, for question-
naires developed in the West, may be further com-
pounded by cultural conceptual differences. Response
rates to telephone or postal questionnaires may be low,
potentially introducing responder bias [11,12]. For these
reasons, previous population surveys of GERD in China
have administered questionnaires using a face-to-face
interview technique, in which subjects completed the
questionnaire while being assisted by trained interviewers
[10,13,14]. This technique has achieved high response
rates and has enabled terms and definitions to be clarified
appropriately for individual respondents.
In order to investigate the prevalence and impact of GERD
in China and facilitate comparisons with other countries,
linguistic and psychometric validation of internationally
recognized disease-specific and generic patient-reported
outcomes instruments is required. The aim of this pilot
study was to develop and validate a methodology for the
epidemiological study of GERD in China. The feasibility,
validity and reliability of several well-designed question-
naires were tested in a Chinese environment using rand-
omized, stratified, multi-stage cluster sampling, a
statistical sampling technique adopted by the World
Health Organization (WHO) [15] that is particularly well
suited to the residential and social administration system
in China.
Methods
Setting
Shanghai, on the east coast of China, is China's largest
city. It is divided into 18 districts and one county, each of
which is classified as urban, suburban, or rural (Figure 1).
Each district includes numerous blocks, which include
The survey sites in Shanghai Figure 1
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multiple residential areas, and the county covers several
towns that govern a number of villages. Broadly speaking,
people who live in an urban area have a city lifestyle,
while people who live in a rural region lead a farming or
country peasant way of life. The suburban lifestyle is inter-
mediate between these two.
Sampling
A randomized, stratified, multi-stage cluster sampling
methodology was used to select a representative sample of
the general population in Shanghai. Huangpu was ran-
domly selected from the nine urban districts, Pudong from
the four suburban districts, and Songjiang from the five
rural districts and one county of Shanghai. Blocks were
randomly selected from districts and residential areas from
blocks so that, finally, four residential areas in the urban
district, three in the suburban district and two in the rural
district were randomly selected (see Figures 1 and 2). The
Residential Committee of each residential area supplied
detailed household rosters of all adults, and subjects for
this study were randomly sampled from these lists.
Pudong District consists of 26 towns and blocks, and is
the biggest district in Shanghai. The residents in this dis-
trict are widely dispersed and not all the information for
each resident could be obtained. As information for all
families in Pudong was available, families were randomly
sampled from the selected residential areas and the family
member with a birthday closest to the investigation date
was selected.
According to the statistical formula n = t2pq/d2 (where n,
t, p, q and d are sample size, t value, positive rate, negative
rate and acceptable error, respectively), assuming a GERD
prevalence of 10%, and setting significance at P = 0.05 and
acceptable error at 2%, the calculated sample size was 864
[16]. According to the 1 in 10 000 sampling proportion
principle and the population size of Shanghai, the target
sample size was 1300 respondents. Combining these two
figures, a target sample size of 1000 valid respondents was
deemed appropriate. Allowing for a 20% non-response
rate, the final intended sample size was set at 1200,
including 400 subjects from each district.
Residents under 18 years of age, or residents who were
illiterate, had severe visual, hearing or learning disabili-
ties, or major psychiatric illness, were excluded from the
survey. Respondents who were not at home after three
attempts to administer the questionnaire were considered
to be missing.
Administration of questionnaires
Local residential committee staff informed residents of
the survey and secured their support and understanding.
The informed consent of respondents was obtained, and
each respondent was free to discontinue participation in
the study at any time. The study was approved by the Sec-
ond Military Medical University Ethics Committee.
During the fieldwork period from November 2005 to Jan-
uary 2006, respondents completed questionnaires in their
own homes or in local residential committee offices.
Questionnaires were self-administered, with trained and
supervised facilitators on hand to explain any questions
that were unclear. The facilitators were social workers at
the site, who were trained by supervisors who were profes-
sionals and graduate students from the Department of
Health Statistics (DoHS), who received training from an
epidemiology survey expert from the DoHS and a gas-
trointestinal specialist from Shanghai Hospital. Quality
auditing was performed to ensure all questionnaires were
completed properly. A valid questionnaire was one that
had been audited and signed by a supervisor.
Questionnaires
Each respondent completed five questionnaires in Man-
darin (see additional file 1: GERD questionnaire in Eng-
lish and Mandarin Chinese): a general information
questionnaire and translations of four concise, well-vali-
dated, internationally recognized and frequently cited dis-
ease-specific and generic health questionnaires, chosen to
facilitate comparison with other studies and minimize the
length of the overall survey: the Reflux Disease Question-
naire (RDQ), the GERD Impact Scale, the Quality of Life
in Reflux and Dyspepsia (QOLRAD) questionnaire, and
the 36-Item Short-Form Health Survey (SF-36). The gen-
eral information questionnaire collected information on
Stratified, multi-stage randomized cluster sampling of urban,  suburban and rural districts in Shanghai Figure 2
Stratified, multi-stage randomized cluster sampling of urban, 
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age, gender, education, income and other general demo-
graphic variables.
The RDQ is a 12-item self-report questionnaire measuring
the frequency and severity of upper gastrointestinal symp-
toms (heartburn, regurgitation and epigastric pain) over
the previous week. Symptom frequency and severity are
scored on a 6-point Likert scale (0–5, where 5 is the most
severe/frequent). A GERD dimension score can be
obtained by combining the heartburn and regurgitation
scores [17]. Subjects reporting heartburn and/or regurgita-
tion of any frequency during the 1-week recall period of
the questionnaire were defined as having GERD. The RDQ
was validated for use in clinical trials in two large studies
[18,19], and was also recently validated for use as a diag-
nostic tool in the DIAMOND study (Diagnostic Tool for
the Management of Patients with Reflux Disease) [20]. A
Chinese version of the RDQ was tested in 10 hospitals in
mainland China, and was found to identify accurately the
presence of symptoms suggestive of GERD experienced
over the previous month [21].
The GERD Impact Scale questionnaire is an eight-item
self-report questionnaire designed to aid patient-physi-
cian communication in primary care. It assesses the fre-
quency of gastroesophageal reflux symptoms over the past
2 weeks and their impact on everyday activities such as
sleep, work, meals and social occasions, and the use of
additional medication (other than that prescribed). Four
response options for frequency are provided (1–4) where
1 is 'all of the time' and 4 is 'none of the time'. This newly
developed tool has demonstrated good psychometric
properties [22].
The GERD-specific version of the QOLRAD questionnaire
is a 25-item disease-specific quality-of-life instrument
measuring the impact of upper gastrointestinal symptoms
over the previous week on five dimensions: emotional
well-being, sleep, vitality, eating/drinking, and physical/
social functioning [23]. The frequencies of effects are
reported using a 7-point Likert scale, with low scores indi-
cating frequent impairment. Its reliability and validity
have been extensively documented in studies of patients
with upper gastrointestinal symptoms [23-25].
The SF-36 is a generic questionnaire assessing health sta-
tus and well-being over the past 4 weeks. It contains 36
items clustered in eight dimensions: physical functioning,
role-physical, bodily pain, general health, vitality, social
functioning, role-emotional, and mental health, plus one
item assessing change in health status over the previous
year [26]. Item scores for each dimension are coded,
summed and transformed to a scale from 0 (worst possi-
ble health state) to 100 (best possible health state). Its
reliability and validity are widely documented across a
range of language versions [27,28].
Translation and cognitive debriefing
Apart from the SF-36, where validated Mandarin transla-
tions already exist [29], questionnaires were translated
and tested in the Department of Medicine, Faculty of Med-
icine, at the University of Hong Kong. Literal translation
of Hong Kong Chinese into mainland Chinese (Manda-
rin) was undertaken by investigators and a panel of main-
land gastroenterologists so that questionnaires were more
interpretable by people from mainland China. This proc-
ess was followed by cognitive debriefing, where five liter-
ate volunteers from mainland China who had a diagnosis
of GERD (heartburn and/or acid regurgitation over the
past year) completed the translated questionnaires and
were interviewed to assess their understanding and inter-
pretation. The overall relevance and clarity of the ques-
tionnaire were assessed using defined responses (very low;
low; moderate; high; very high) and subjects were asked to
specify any items that they regarded as irrelevant or
unclear. Subjects considered the questions to be relevant
and clear (grading: moderate to very high). No additional
revisions were required.
Statistical analysis
Data management
Questionnaire responses were coded and double-entered
by two independent professional data-entry staff from the
DoHS. EpiData software [30] was used to check for con-
sistency between the two sets of data entries to ensure data
quality. For the RDQ, QOLRAD, and SF-36, where at least
50% of items in a dimension were completed, the mean
value of the completed items was used to impute the miss-
ing values. Where more than 50% of items were missing,
the dimension score was excluded from the analysis [31-
33]. For the GERD Impact Scale, if an item score was miss-
ing, imputation was not performed and the score was
excluded from the analysis.
SAS 9.1.3 (SAS, Shanghai, China) and SPSS 10.0 software
(SPSS Inc., Shanghai, China) were used to complete data
analyses. All hypothesis tests used two-side tests and set
alpha at 0.05. A two-tailed P-value of 0.05 or less was con-
sidered to indicate statistical significance. Different
groups of subjects were compared by ANOVA for nor-
mally distributed continuous data, Fisher's exact test for
categorical variables and the Cochran-Mantel-Haenszel
test for ranked variables.
Reliability
Internal consistency was evaluated using Cronbach's
alpha coefficient to determine the extent to which items
within each questionnaire were interrelated [34]. Cron-
bach's alpha coefficients for each questionnaire were cal-BMC Gastroenterology 2008, 8:37 http://www.biomedcentral.com/1471-230X/8/37
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culated by correlating all individual item scores with
dimension scores and/or the overall score. An alpha coef-
ficient above 0.70 suggests good internal consistency and
reliability.
Test-retest reliability is a measure of the stability of the
instrument under different conditions with the same
respondent; in this study, it was assessed by retesting 10%
of respondents (n = 40 from each region) 2–7 days after
the baseline test. Cohen's kappa coefficient and the intra-
class correlation coefficient (ICC) were used to analyze
the test-retest reliability of the survey instruments.
Cohen's kappa coefficient was used in the analysis of cat-
egorical and ranked measurements, while ICC was used to
analyze quantitative measurements. A test-retest coeffi-
cient above 0.70 was considered acceptable [35].
Construct validity
Construct validity evaluates whether an instrument actu-
ally measures the phenomena that it theoretically pre-
dicts; correlation and factor analysis were used to evaluate
construct validity in this study. Factor analysis using prin-
cipal component analysis and quartimax rotation
explored whether the factor structure of each question-
naire was supported. Factor loadings larger than 0.50
within one dimension were considered to support the fac-
tor construct provided the factor loadings were low across
the other dimensions, with cumulative rates used to show
the contributions of combinations of principal compo-
nents [36]. Correlation analysis tested the construct valid-
ity of questionnaires containing multiple dimensions (i.e.
RDQ, QOLRAD and SF-36). The analysis measured the
strength of association between dimension scores and the
total score for QOLRAD and SF-36 questionnaires, and
between item scores and dimension scores for the RDQ. A
strong correlation coefficient was considered to be over
0.6, a moderate correlation, 0.3–0.6, and a weak correla-
tion below 0.3 [37].
Convergent validity analyzes whether the postulated
dimension of an instrument correlates appreciably with
all other dimensions from other instruments that should
theoretically be related to it. Convergent validity was
investigated in this study by correlating the GERD dimen-
sion from the RDQ with SF-36 and QOLRAD dimensions,
and SF-36 dimensions with QOLRAD total score. A
decrease in health-related quality of life was expected for
respondents with GERD symptoms.
Results
Response rate
Of the 1200 randomly pre-selected subjects, 1034 agreed
to be interviewed (a response rate of 86%). In the Pudong
District, a total of 112 respondents' questionnaires were
withdrawn from the statistical analysis due to one facilita-
tor's failure to adhere to the study protocol. A further three
questionnaires from the Huangpu District were excluded
due to incompleteness. Therefore, a total of 919 question-
naires (359 from the urban region, 224 from the subur-
ban region, and 336 from the rural region) were included
in the analysis after quality auditing. The mean response
rates for items in each questionnaire are provided in Table
1.
Of 120 subjects randomly selected for retest, 113 agreed
to be re-interviewed (a 94% response rate). Fourteen
questionnaires were rejected because they were not com-
pleted in line with the study protocol, leaving 99 ques-
tionnaires for inclusion in the retest analysis.
Respondents
The respondents' average age was 47 years (ranging from
18 to 77 years); 55% were female and the majority of
respondents (85%) were married. Most respondents did
not smoke (74%) or drink alcohol (83%). The average
BMI was 22.6 kg/m2, with a range of 14.4–36.5 kg/m2.
Level and years of education, current job type and income
level all varied significantly between the three regions (p
< 0.0001). Education levels and family income were great-
est for the urban region and lowest for the rural region
(Table 2), reflecting the socioeconomic divide that exists
between urban and rural China. Forty percent of urban
respondents were professionals or technicians, while 73%
of rural respondents and 44% of suburban respondents
were agricultural or fishery workers.
Table 1: Mean item response rates by questionnaire and by region.
Mean item response rates
Region RDQ GERD Impact Scale QOLRAD SF-36
Urban (n = 359) 98.35–98.62% 98.07–98.35% 96.97–100% 98.07–99.45%
Suburban (n = 224) 100–100% 100–100% 100–100% 98.21–100%
Rural (n = 336) 100–100% 100–100% 94.11–100% 97.92–99.70%
All regions (n = 919) 99.35–99.46% 99.24–99.35% 98.25–100% 98.59–99.67%
GERD: gastroesophageal reflux disease; QOLRAD: Quality of Life in Reflux and Dyspepsia questionnaire; RDQ: Reflux Disease Questionnaire; SF-
36: 36-item Short-Form Health Survey.BMC Gastroenterology 2008, 8:37 http://www.biomedcentral.com/1471-230X/8/37
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Reliability
In the test-retest analysis, Cohen's kappa coefficients
ranged from 0.66 to 1.00 for RDQ dimensions, 0.49 to
1.00 for GERD Impact Scale items, and 0.79 to 1.00 for
QOLRAD dimensions. The test-retest ICC ranged from
0.69 to 0.97 for seven dimensions of the SF-36 question-
naire, while one (role-emotional) was close to zero
(0.01). Internal consistency (indicated by Cronbach's
Table 2: Demographics and baseline characteristics of respondents by region.
Mean ± SD or number of subjects (%)
Variables Urban (n = 359*) Suburban (n = 224*) Rural (n = 336*) Total (n = 919*)
Age (years) 45.7 ± 14.5 45.2 ± 13.1 49.0 ± 12.2 46.7 ± 13.4
Weight (kg) 63.0 ± 11.0 61.2 ± 10.1 59.3 ± 8.2 61.2 ± 10.0
Height (cm) 167.3 ± 8.2 162.8 ± 7.7 162.0 ± 6.8 164.3 ± 8.0
Body mass index (kg/m2) 22.4 ± 3.0 23.1 ± 3.3 22.6 ± 2.7 22.6 ± 3.0
Sex
Female 193 (53.8) 139 (62.1) 177 (52.7) 509 (55.4)
Male 166 (46.2) 85 (38.0) 159 (47.3) 410 (44.6)
Marital status
Married 266 (75.1) 197 (88.7) 306 (94.2) 796 (85.4)
Unmarried 88 (24.9) 25 (11.3) 19 (5.9) 132 (14.7)
Maximum education level
Primary school/uneducated 4 (1.1) 61 (27.2) 189 (56.8) 254 (27.7)
Secondary/high school 232 (64.6) 138 (61.6) 139 (41.7) 509 (55.6)
College graduate or beyond 123 (34.3) 25 (11.2) 5 (1.5) 153 (16.7)
Years of school education 12.3 ± 2.5 8.9 ± 3.7 6.2 ± 3.6 9.3 ± 4.2
Current job
Government employee 20 (5.6) 1 (0.5) 1 (0.3) 22 (2.4)
Professional or technician 144 (40.3) 18 (8.0) 12 (3.6) 174 (19.02)
Blue-collar worker 70 (19.6) 40 (17.9) 51 (15.3) 161 (17.6)
Agricultural or fisheries worker 1 (0.3) 98 (43.8) 243 (72.8) 342 (37.4)
Student in school 30 (8.4) 7 (3.1) 4 (1.2) 41 (4.5)
Others 92 (25.7) 60 (26.8) 23 (6.9) 175 (19.1)
Total family income per month†
less than 1999 Yuan 178 (50.9) 124 (57.1) 232 (69.2) 534 (59.2)
2000–4999 Yuan 157 (44.9) 81 (37.3) 98 (29.3) 336 (37.3)
5000–9999 Yuan 13 (3.7) 12 (5.4) 4 (1.2) 29 (3.2)
10000 Yuan or above 2 (0.6) 0 (0) 1 (0.3) 3 (0.3)
Smoking
No 282 (78.6) 163 (73.4) 225 (68.2) 670 (73.6)
Yes 77 (21.5) 59 (26.6) 105 (31.8) 241 (26.5)
Years of smoking 22.5 ± 11.6 20.6 ± 12.6 19.63 ± 11.7 20.8 ± 11.9
Alcohol intake
No 308 (85.8) 193 (87.3) 251 (76.1) 752 (82.6)
Yes 51 (14.2) 28 (12.7) 79 (23.4) 158 (17.4)
Years of alcohol intake 18.7 ± 11.1 21.06 ± 11.9 18.26 ± 10.9 18.69 ± 11.1
*Totals may not tally exactly where individual subjects have refused to answer a specific question.
†2000 Yuan is equivalent to approximately 260 USD, at an approximate exchange rate of 7.7 Yuan = 1 USD (April 2007).
Table 3: Reliability of questionnaires.
Questionnaire Number of items Test-retest reliability coefficient* Cronbach's alpha coefficient
RDQ 12 0.80 0.86
GERD Impact Scale 8 0.71 0.80
QOLRAD 25 0.93 0.98
SF-36 36 0.96 0.90
*Cohen's kappa coefficient for the RDQ, GERD Impact Scale and QOLRAD; intraclass correlation coefficient for SF-36. GERD: gastroesophageal 
reflux disease; RDQ: Reflux Disease Questionnaire; QOLRAD: Quality of Life in Reflux and Dyspepsia questionnaire; SF-36: 36-Item Short-Form 
Health Survey.BMC Gastroenterology 2008, 8:37 http://www.biomedcentral.com/1471-230X/8/37
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alpha coefficient) ranged from 0.65 to 0.97 for QOLRAD
dimensions. For SF-36, seven dimensions ranged from
0.69 to 0.95, while one (social functioning) was 0.31. The
test-retest reliability coefficient and total Cronbach's
alpha coefficient for each questionnaire are shown in
Table 3. All coefficients were ≥ 0.7, demonstrating good
reliability and internal consistency for each questionnaire.
Construct validity
Each dimension score was highly correlated with the total
score for both QOLRAD and SF-36 (p < 0.001), indicating
good construct validity. For QOLRAD, Spearman correla-
tion coefficients ranged from 0.77 for physical/social
functioning to 0.91 for food and drink problems and for
vitality, among respondents reporting symptoms of heart-
burn and/or regurgitation via the RDQ. For SF-36, Spear-
man correlation coefficients ranged from 0.53 for social
functioning to 0.77 for general health, for the study pop-
ulation as a whole. The RDQ also demonstrated good
construct validity (Table 4), with each dimension correlat-
ing most strongly with the individual items comprising it
(Spearman correlation coefficients 0.62–0.94). Regurgita-
tion items correlated strongly with the GERD dimension
as expected, but the weaker correlation with heartburn
items may have been due to the low prevalence of heart-
burn in the Shanghai population.
Factor analysis was used to explore whether the predicted
factor structure of the questionnaire was supported. Cred-
ible construct validity was demonstrated for the RDQ,
GERD Impact Scale and SF-36 questionnaires. All RDQ
items correlated as expected in the factor analysis apart
from the frequency and severity of 'pain behind breast-
bone', which correlated more strongly with the epigastric
pain dimension than the heartburn dimension (Table 5).
The cumulative rate of the three factors was 72.1%. All
GERD Impact Scale items correlated with factors as
expected (Table 6). The cumulative rate of the four factors
was 78.0%.
For SF-36, the cumulative rate of the eight factors plus
health transition item was 71.3%. Most items correlated
with factors as expected (see Table 7), with particularly
high correlations seen for role-physical and bodily pain
dimensions. The physical functioning (PF) items were dis-
tributed into two dimensions; PFa included moderate to
vigorous activities such as lifting or carrying groceries,
climbing several flights of stairs and walking more than
one mile, whereas PFb included less strenuous activities
such as climbing one flight of stairs, bending, kneeling,
walking one or several blocks, and bathing or dressing
oneself. The social function dimension was unclear, dis-
tributing to mental health and role-emotional dimen-
sions. In addition, two items from the vitality dimension,
two from the mental health dimension and one from the
physical functioning dimension were distributed into the
general health dimension. The three role-emotional items
showed a tendency towards distribution into the role-
physical dimension, although the correlation coefficients
were lower than those for distribution into the expected
role-emotional dimension.
The factor analysis showed that the construct validity of
QOLRAD was not as good as expected, as items were not
distributed to the appropriate dimensions (Table 8).
Convergent validity
The RDQ GERD score was negatively correlated with all
QOLRAD dimensions; correlations were statistically sig-
nificant for the QOLRAD dimensions of food and drink
Table 4: Spearman correlation coefficient between RDQ item score and RDQ dimension score.
RDQ item Heartburn dimension Regurgitation dimension GERD dimension Epigastric pain dimension
Burning behind breastbone – 
severity
0.62 0.34 0.38 0.32
Burning behind breastbone – 
frequency
0.62 0.34 0.38 0.32
Pain behind breastbone – severity 0.93 0.32 0.56 0.59
Pain behind breastbone – 
frequency
0.93 0.32 0.56 0.59
Acid taste – severity 0.32 0.91 0.84 0.44
Acid taste – frequency 0.32 0.91 0.84 0.43
Movement of materials – severity 0.42 0.72 0.67 0.39
Movement of materials – 
frequency
0.43 0.72 0.67 0.39
Upper stomach burning – severity 0.54 0.41 0.44 0.68
Upper stomach burning – 
frequency
0.54 0.41 0.44 0.68
Upper stomach pain – severity 0.58 0.45 0.56 0.94
Upper stomach pain – frequency 0.58 0.45 0.56 0.94
Numbers in bold indicate correlation coefficient ≥ 0.6.
GERD: gastroesophageal reflux disease; RDQ: Reflux Disease QuestionnaireBMC Gastroenterology 2008, 8:37 http://www.biomedcentral.com/1471-230X/8/37
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problems (p = 0.037, correlation coefficient -0.28) and
social functioning (p = 0.003, correlation coefficient -
0.39). The RDQ GERD score was also significantly nega-
tively correlated with all dimensions of SF-36 (p ≤ 0.001).
SF-36 correlation coefficients ranged from -0.11 (social
functioning) to -0.34 (bodily pain). Correlations were
negative because health-related quality of life decreases as
symptoms and their impact increase.
The RDQ GERD score correlated most strongly with bod-
ily pain (the SF-36 dimension most impaired by GERD in
previous studies), reflecting the fact that GERD is prima-
rily a painful disease. All eight SF-36 dimensions were sig-
nificantly correlated with the QOLRAD total score (p ≤
0.001, correlation coefficients ranged from 0.16–0.29),
supporting the construct validity of QOLRAD and SF-36.
Discussion
This pilot study used several well-designed question-
naires, administered together, with the aim of developing
and validating a methodology for the epidemiological
study of GERD in China. Using a randomized, stratified,
multi-stage cluster sampling technique, we validated Chi-
nese translations of the SF-36, QOLRAD questionnaire,
GERD Impact Scale and RDQ. In this study, the translated
and adapted questionnaires demonstrated reproducibility
and internal consistency within the methodology
adopted, although responsiveness was not assessed. Each
questionnaire had a test-retest reliability coefficient larger
than 0.7 and a high Cronbach's alpha coefficient (≥ 0.8),
suggesting good reliability. The construct validity of ques-
tionnaires was also credible in this survey, although the
QOLRAD did not perform well in the factor analysis. This
Table 5: Factor analysis matrix of RDQ items in three factors (heartburn, regurgitation and epigastric pain).
Symptom Heartburn Regurgitation Epigastric pain
Heartburn
Burning behind breastbone – severity 0.84 0.22 0.31
Burning behind breastbone – frequency 0.84 0.11 0.37
Pain behind breastbone – severity 0.25 0.05 0.80
Pain behind breastbone – frequency 0.10 0.04 0.84
Regurgitation
Acid taste – severity -0.09 0.89 0.16
Acid taste – frequency -0.07 0.84 0.15
Movement of materials – severity 0.33 0.72 0.17
Movement of materials – frequency 0.36 0.72 0.17
Epigastric pain
Upper stomach burning – severity 0.31 0.12 0.59
Upper stomach burning – frequency 0.36 0.01 0.63
Upper stomach pain – severity -0.18 0.27 0.83
Upper stomach pain – frequency -0.15 0.14 0.88
Numbers in bold indicate correlation coefficient ≥ 0.5.
RDQ: Reflux Disease Questionnaire.
Table 6: Factor analysis matrix of GERD Impact Scale items in four factors.
Symptom (frequency) Regurgitation and effect 
on eat/sleep/work
Heartburn and effect on 
sleep
Additional medication Sore throat/hoarseness
Pain behind breastbone 0.37 0.73 0.18 -0.28
Burning behind breastbone 0.23 0.76 0.00 0.40
Acid taste or regurgitation 0.83 0.10 -0.05 0.04
Sore throat or hoarseness 
due to heartburn or acid 
reflux
0.39 0.21 0.09 0.81
Difficulty sleeping due to 
heartburn or acid reflux
0.53 0.61 -0.02 0.20
Difficulty eating preferred 
foods due to heartburn or 
acid reflux
0.82 0.00 0.25 0.11
Difficulty working due to 
heartburn or acid reflux
0.77 0.31 0.05 0.04
Self-medication for 
heartburn or acid reflux
0.29 0.13 0.92 0.07
Numbers in bold indicate correlation coefficient ≥ 0.5.BMC Gastroenterology 2008, 8:37 http://www.biomedcentral.com/1471-230X/8/37
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was likely to be due to linguistic and cultural translation
problems: facilitators considered that some items were
difficult to explain to respondents, particularly for those
with a low level of education.
The sampling and administration techniques contributed
substantially to the success of this study. By gaining the
support of local residential communities, a high response
rate of 86% was achieved, which is likely to prevent signif-
icant responder bias. The provision of assistance from
trained facilitators helped avoid potential cultural and lin-
guistic confusion, providing a relatively precise interpreta-
tion of the items in the questionnaire, and is
recommended for future epidemiological studies using
this survey instrument in order to ensure accuracy.
Chinese translations of the SF-36 have previously under-
gone psychometric validation among Chinese-speaking
peoples in mainland China, the USA, Hong Kong and Tai-
wan [29,38-41]. These studies demonstrated satisfactory
psychometric characteristics for SF-36 in these groups,
while highlighting a level of cultural variation between
Western and Chinese versions and between the different
Chinese cultures. There is a tendency, also reflected in the
current study, for the social functioning dimension to per-
form less well in China [29]; Li and colleagues have com-
mented that this points to the Confucian ideology of
collectivism in China, where it is socially unacceptable for
Chinese to use 'sickness' as an excuse to avoid working or
socializing [29].
Table 7: Factor analysis matrix of SF-36 items in nine factors.
Item GH RP PFa PFb MH RE BP VT HT
PF1 0.51 0.10 -0.03 0.65 -0.03 -0.01 0.06 0.10 0.08
PF2 0.33 0.18 0.12 0.73 0.12 0.12 -0.07 0.02 0.12
PF3 0.34 0.15 0.20 0.72 0.11 0.04 0.12 0.02 0.10
PF4 0.33 -0.02 0.32 0.64 0.14 0.04 0.06 -0.02 0.23
PF5 0.16 0.11 0.81 0.19 0.01 0.10 0.08 0.06 0.04
PF6 0.16 0.02 0.57 0.34 0.10 0.13 0.26 0.05 0.14
PF7 0.41 0.03 0.30 0.56 -0.05 0.01 -0.01 0.11 -0.23
PF8 0.36 0.04 0.49 0.46 0.06 -0.11 -0.07 -0.04 -0.15
PF9 0.13 0.13 0.88 0.08 0.12 -0.03 0.01 -0.02 -0.01
PF10 0.10 0.12 0.89 0.03 0.06 0.00 -0.06 0.00 -0.02
RP1 0.20 0.91 0.07 0.03 0.10 0.14 0.05 0.03 0.08
RP2 0.18 0.90 0.08 0.04 0.09 0.13 0.05 0.03 0.09
RP3 0.18 0.88 0.09 0.08 0.10 0.14 0.14 0.03 0.06
RP4 0.18 0.82 0.14 0.11 0.10 0.06 0.19 0.02 0.03
RE1 0.17 0.58 -0.01 0.07 0.13 0.72 0.04 0.02 -0.01
RE2 0.18 0.59 0.06 0.07 0.12 0.72 0.04 0.02 -0.02
RE3 0.13 0.48 0.07 0.09 0.09 0.73 0.05 0.05 -0.04
MH1 0.19 0.11 -0.03 0.06 0.62 0.13 0.18 0.15 -0.09
MH2 0.25 0.15 0.14 0.13 0.64 0.21 -0.06 0.08 0.15
MH3 0.57 0.05 0.03 0.07 0.37 -0.08 -0.03 -0.08 -0.25
MH4 0.20 0.12 0.18 0.02 0.69 0.11 -0.07 0.18 0.21
MH5 0.63 0.04 0.04 0.11 0.06 -0.01 -0.21 0.29 -0.17
VT1 0.76 0.10 0.05 0.27 0.19 -0.09 0.10 0.01 -0.17
VT2 0.78 0.13 0.05 0.25 0.17 -0.06 0.08 0.01 -0.15
VT3 0.27 0.05 0.05 0.04 0.13 0.04 0.08 0.86 0.05
VT4 0.37 0.10 0.02 0.10 0.19 -0.05 0.07 0.75 -0.03
SF1 0.23 0.27 0.16 -0.01 0.22 0.46 0.26 -0.18 0.07
SF2 0.27 0.18 0.08 0.06 0.64 -0.11 0.02 -0.07 -0.13
GH1 0.59 0.15 0.06 0.15 -0.06 0.10 0.16 0.00 0.43
GH2 0.68 0.10 0.02 0.03 0.10 0.12 0.05 0.13 0.13
GH3 0.73 0.07 0.19 -0.03 0.02 0.12 -0.01 0.02 0.08
GH4 0.61 0.05 -0.01 0.06 0.09 0.05 0.07 0.03 0.44
GH5 0.74 0.16 0.09 0.13 -0.03 0.14 0.16 0.06 0.18
BP1 0.20 0.24 0.07 0.04 0.04 0.08 0.86 0.05 0.09
BP2 0.20 0.32 0.07 0.07 0.03 0.06 0.83 0.09 0.04
HT 0.15 0.27 0.04 0.20 0.03 -0.06 0.09 -0.01 0.68
Numbers in bold indicate expected distribution with correlation coefficient ≥ 0.5. Underlined numbers indicate aberrant distribution. BP: bodily 
pain; GERD: gastroesophageal reflux disease; GH: general health; HT: health transition; MH: mental health; PF: physical function (PFa: strenuous 
activities; PFb: light activities); RE: role–emotional; RP: role–physical; SF: social function; SF-36: short form-36; VT: vitality.BMC Gastroenterology 2008, 8:37 http://www.biomedcentral.com/1471-230X/8/37
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In several previous studies vitality was more strongly asso-
ciated with mental health than physical health [29,38-
40], which may relate to traditional Chinese medicine,
where fatigue associated with depression is conceptual-
ized as a deficiency of vital energy or 'qi'. Although this
was not the case in the current study, two items in the
vitality dimension were more strongly distributed to gen-
eral health. These issues illustrate the importance of exam-
ining the psychometric validity of instruments in different
ethnic groups with cultural differences in language, values
and perceptions of health.
This study has several limitations. Some subjects found
the combined questionnaire too long and repetitive: a
general information questionnaire, the RDQ, GERD
Impact Scale, QOLRAD and SF-36 combined to make a
total of 137 items and, on average, the questionnaire took
about 20 minutes to complete. Responsiveness to change
and known-groups validity were not assessed. Where con-
struct validity was assessed, the different recall periods for
individual questionnaires may have weakened convergent
correlation results, while the short retest period may dis-
tort the reliability analysis where respondents remember
their previous responses. The methodology was unable to
sample migrant workers, who make up a significant por-
tion of the Shanghai population, as they remain officially
registered in their place of origin.
Conclusion
The experience gained in this pilot study will inform a
planned larger study of the epidemiology of GERD across
mainland China, which will establish the wider preva-
lence of GERD symptoms in China using representative
study populations and a standardized, well-validated
methodology. The survey questionnaire will be reduced in
length and simplified, and symptoms will be assessed
using the RDQ with a longer recall period (4 weeks). The
QOLRAD questionnaire will be removed from the survey,
due to its relatively poor performance in the factor analy-
sis. Ideally, responsiveness to change and known-groups
validity should be studied to investigate further the valid-
ity of the survey instruments. Health-related quality of life
will be evaluated using the SF-36, and sleep disturbance
will be investigated using the Epworth Sleepiness Scale
(ESS). Endoscopic examination of randomly sampled
subjects would also be informative, to allow comparison
with recent studies conducted in the West [42,43].
In summary, this study developed and tested a successful
survey methodology for the epidemiological study of
GERD in China. The questionnaires used demonstrated
credible reliability and construct validity, supporting their
use in larger epidemiological surveys of GERD in China,
and allowing the results of this study to be extrapolated to
the general population of East China.
Competing interests
This study was supported by AstraZeneca R&D, Mölndal,
Sweden. Writing support was provided by Chris Winches-
ter and Claire Mulligan of Oxford PharmaGenesis and
funded by AstraZeneca R&D, Mölndal, Sweden. Jia He has
served as the director of the Department of Health Statis-
tics, Second Military Medical University and WHO/TDR
Clinical Data Management Center, Shanghai, China, and
also served as a director of the Chinese Biomedicine Sta-
tistics Institute. Jia He has received research funding from
the National Natural Science Foundation of China, WHO
and Shanghai Natural Science Foundation. Saga Johans-
son is an employee of AstraZeneca R&D, Mölndal, Swe-
den, and Mari-Ann Wallander was an employee of
AstraZeneca R&D, Mölndal, Sweden at the time of the
study.
Authors' contributions
YC and XY participated in the acquisition of data, analysis
and interpretation of data, and drafting the article. XQM
and RW participated in the analysis and interpretation of
data, and drafting and critically revising the article. SJ and
MAW participated in the conception and design of the
Table 8: Factor analysis matrix of QOLRAD items in five 
factors.
Item Factors
12345
Q4001 0.797
Q4002 0.526 0.784
Q4003 0.677 0.576
Q4004 0.874
Q4005 0.808
Q4006 0.852
Q4007 0.879
Q4008 0.829
Q4009 0.826
Q4010 0.903
Q4011 0.867
Q4012 0.912
Q4013 0.890
Q4014 0.812
Q4015 0.931
Q4016 0.736
Q4017 0.879
Q4018 0.954
Q4019 0.940
Q4020 0.516 0.794
Q4021 0.796 0.557
Q4022 0.825
Q4023 0.938
Q4024 0.954
Q4025 0.930
QOLRAD: Quality of Life in Reflux and Dyspepsia.BMC Gastroenterology 2008, 8:37 http://www.biomedcentral.com/1471-230X/8/37
Page 11 of 12
(page number not for citation purposes)
study, and critically revising the article. JH made substan-
tial contributions to the conception and design of the
study, supervised all aspects of its implementation, and
critically revised the article. All authors read and approved
the final manuscript.
Additional material
Acknowledgements
This study was supported by AstraZeneca R&D, Mölndal, Sweden. We 
thank the participating general practitioners for their collaboration, and the 
Centers of Disease Control and Prevention of Huangpu District, Songjiang 
District and Pudong District in Shanghai for providing the assistance in field 
work. We thank Dr Chris Winchester and Dr Claire Mulligan, from Oxford 
PharmaGenesis, who provided medical writing support funded by Astra-
Zeneca. We also thank Dr Benjamin Wong and Dr Xiaohua Jin for trans-
lating the questionnaires used in this study.
References
1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R: The Montreal
definition and classification of gastroesophageal reflux dis-
ease: a global evidence-based consensus.  Am J Gastroenterol
2006, 101:1900-20; quiz 1943.
2. Dent J, El-Serag HB, Wallander MA, Johansson S: Epidemiology of
gastro-oesophageal reflux disease: a systematic review.  Gut
2005, 54:710-717.
3. El-Serag HB: Time trends of gastroesophageal reflux disease:
a systematic review.  Clin Gastroenterol Hepatol 2007, 5:17-26.
4. Wong WM, Lim P, Wong BC: Clinical practice pattern of gastro-
enterologists, primary care physicians, and otolaryngologists
for the management of GERD in the Asia-Pacific region: the
FAST survey.  J Gastroenterol Hepatol 2004, 19 Suppl 3:S54-60.
5. Wong BC, Kinoshita Y: Systematic review on epidemiology of
gastroesophageal reflux disease in Asia.  Clin Gastroenterol Hepa-
tol 2006, 4:398-407.
6. McColl E, Junghard O, Wiklund I, Revicki DA: Assessing symptoms
in gastroesophageal reflux disease: how well do clinicians'
assessments agree with those of their patients?  Am J Gastroen-
terol 2005, 100:11-18.
7. Spechler SJ, Jain SK, Tendler DA, Parker RA: Racial differences in
the frequency of symptoms and complications of gastro-
oesophageal reflux disease.  Aliment Pharmacol Ther 2002,
16:1795-1800.
8. Ministry of Education: Language survey of 500,000 Chinese.  Bei-
jing, Xinhua; 2007. 
9. Wu J: Status of the population of China, 2002: Analysis of
market and population (Chinese).  2003, 9:45-48.
10. Wang JH, Luo JY, Dong L, Gong J, Tong M: Epidemiology of gas-
troesophageal reflux disease: a general population-based
study in Xi'an of Northwest China.  World J Gastroenterol 2004,
10:1647-1651.
11. Wong WM, Lai KC, Lam KF, Hui WM, Hu WH, Lam CL, Xia HH,
Huang JQ, Chan CK, Lam SK, Wong BC: Prevalence, clinical spec-
trum and health care utilization of gastro-oesophageal reflux
disease in a Chinese population: a population-based study.
Aliment Pharmacol Ther 2003, 18:595-604.
12. Parker C, Dewey M: Assessing research outcomes by postal
questionnaire with telephone follow-up. TOTAL Study
Group. Trial of Occupational Therapy and Leisure.  Int J Epi-
demiol 2000, 29:1065-1069.
13. Pan G, Xu G, Ke MY, Han S, Guo H, Li Z, Fang X, Zou D, Lu SR, Liu
J: Epidemiological study of symptomatic gastroesophageal
reflux disease in China: Beijing and Shanghai.  Chin J Dig Dis
2000, 1:2-8.
14. Chen M, Xiong L, Chen H, Xu A, He L, Hu P: Prevalence, risk fac-
tors and impact of gastroesophageal reflux disease symp-
toms: a population-based study in South China.  Scand J
Gastroenterol 2005, 40:759-767.
15. World Health Organisation: The World Health Survey (WHS).
Sampling guidelines for participating countries.   [http://
www.who.int/healthinfo/survey/whssamplingguidelines.pdf].
16. Campbell MJ, Julious SA, Altman DG: Estimating sample sizes for
binary, ordered categorical, and continuous outcomes in
two group comparisons.  BMJ 1995, 311:1145-1148.
17. Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, Fen-
drick AM, Jones R, Dent J, Bytzer P: Initial validation of a diagnos-
tic questionnaire for gastroesophageal reflux disease.  Am J
Gastroenterol 2001, 96:52-57.
18. Veldhuyzen van Zanten SV, Armstrong D, Barkun A, Junghard O,
White RJ, Wiklund IK: Symptom overlap in patients with upper
gastrointestinal complaints in the Canadian confirmatory
acid suppression test (CAST) study: further psychometric
validation of the reflux disease questionnaire.  Aliment Pharma-
col Ther 2007, 25:1087-1097.
19. Johnsson F, Hatlebakk J, Klintenberg AC, Roman J: The symptom
relieving effect of esomeprazole 40 mg daily in patients with
heartburn.  Scand J Gastroenterol 2003, 38(4):347-353.
20. Dent J, Vakil N, Jones R, Reimitz PE, Schöning U, Halling K, Junghard
O, Lind T: Validation of the reflux disease questionnaire for
the diagnosis of gastroesophageal reflux disease in primary
care.  Gut 2007, 56:A75.
21. Chinese Gastroesophageal Reflux Disease Study Group: Value of
reflux diagnostic questionnaire in the diagnosis of gastro-
esophageal reflux disease.  Chin J Dig Dis 2004, 5:51-55.
22. Jones R, Coyne K, Wiklund I: The Gastroesophageal Reflux Dis-
ease Impact Scale - a patient management tool for primary
care.  Aliment Pharmacol Ther 2007, 25:1451-1459.
23. Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen
van Zanten S, Pare P, Chiba N, Leddin DS, Bigard MA, Colin R, Sch-
oenfeld P: Quality of Life in Reflux and Dyspepsia patients.
Psychometric documentation of a new disease-specific ques-
tionnaire (QOLRAD).  Eur J Surg Suppl 1998:41-49.
24. Kulich KR, Wiklund I, Junghard O: Factor structure of the Qual-
ity of Life in Reflux and Dyspepsia (QOLRAD) questionnaire
evaluated in patients with heartburn predominant reflux dis-
ease.  Qual Life Res 2003, 12:699-708.
25. Talley NJ, Fullerton S, Junghard O, Wiklund I: Quality of life in
patients with endoscopy-negative heartburn: reliability and
sensitivity of disease-specific instruments.  Am J Gastroenterol
2001, 96:1998-2004.
26. Ware JE Jr., Sherbourne CD: The MOS 36-item short-form
health survey (SF-36). I. Conceptual framework and item
selection.  Med Care 1992, 30:473-483.
27. Ware JE Jr., Gandek B, Kosinski M, Aaronson NK, Apolone G, Brazier
J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M, Thunedborg K:
The equivalence of SF-36 summary health scores estimated
using standard and country-specific algorithms in 10 coun-
tries: results from the IQOLA Project. International Quality
of Life Assessment.  J Clin Epidemiol 1998, 51:1167-1170.
28. Ware JE Jr., Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech
P, Brazier J, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M: The
factor structure of the SF-36 Health Survey in 10 countries:
results from the IQOLA Project. International Quality of
Life Assessment.  J Clin Epidemiol 1998, 51:1159-1165.
29. Li L, Wang HM, Shen Y: Chinese SF-36 Health Survey: transla-
tion, cultural adaptation, validation, and normalisation.  J Epi-
demiol Community Health 2003, 57:259-263.
30. Lauritsen JM: EpiData data entry, data management and basic
statistical analysis system.   [Http://www.epidata.dk].
Additional file 1
A pilot survey of GERD incidence in general population, China. English 
and Mandarin Chinese translations of a survey instrument for the study 
of gastroesophageal reflux disease (GERD) in China, including a general 
information questionnaire, the Reflux Disease Questionnaire, the Quality 
of Life in Reflux and Dyspepsia Questionnaire, and the GERD Impact 
Scale.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
230X-8-37-S1.pdf]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Gastroenterology 2008, 8:37 http://www.biomedcentral.com/1471-230X/8/37
Page 12 of 12
(page number not for citation purposes)
31. Ware JE, Snow KK, Kosinski M, Gandek B: SF-36 health survey
manual and interpretation guide.  Boston, New England Medical
Center, The Health Institute; 1993. 
32. McHorney CA, Ware JE Jr., Lu JF, Sherbourne CD: The MOS 36-
item Short-Form Health Survey (SF-36): III. Tests of data
quality, scaling assumptions, and reliability across diverse
patient groups.  Med Care 1994, 32:40-66.
33. Gandek B, Ware JE Jr., Aaronson NK, Alonso J, Apolone G, Bjorner
J, Brazier J, Bullinger M, Fukuhara S, Kaasa S, Leplege A, Sullivan M:
Tests of data quality, scaling assumptions, and reliability of
the SF-36 in eleven countries: results from the IQOLA
Project. International Quality of Life Assessment.  J Clin Epide-
miol 1998, 51:1149-1158.
34. Cronbach LJ: Coefficient alpha and the internal structure of
tests.  Psychometrika 1951, 16:297-334.
35. Fitzpatrick R, Davey C, Buxton MJ, Jones DR: Evaluating patient-
based outcome measures for use in clinical trials.  Health Tech-
nol Assess 1998, 2:i-iv, 1-74.
36. Fang J: Medical statistics and computer experiments.  Singa-
pore, Stallion Press; 2005. 
37. Hinkle DE, Jurs SG, Wiersma W: Applied statistics for the behav-
ioural sciences.  2nd edition. Boston, Houghton Mifflin; 1988. 
38. Chang DF, Chun CA, Takeuchi DT, Shen H: SF-36 health survey:
tests of data quality, scaling assumptions, and reliability in a
community sample of Chinese Americans.  Med Care 2000,
38:542-548.
39. Ren XS, Amick B 3rd, Zhou L, Gandek B: Translation and psycho-
metric evaluation of a Chinese version of the SF-36 Health
Survey in the United States.  J Clin Epidemiol 1998, 51:1129-1138.
40. Tseng HM, Lu JF, Gandek B: Cultural Issues in Using the SF-36
Health Survey in Asia: Results from Taiwan.  Health Qual Life
Outcomes 2003, 1:72.
41. Lam CL, Gandek B, Ren XS, Chan MS: Tests of scaling assump-
tions and construct validity of the Chinese (HK) version of
the SF-36 Health Survey.  J Clin Epidemiol 1998, 51:1139-1147.
42. Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-
Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ,
Agreus L: High prevalence of gastroesophageal reflux symp-
toms and esophagitis with or without symptoms in the gen-
eral adult Swedish population: a Kalixanda study report.
Scand J Gastroenterol 2005, 40:275-285.
43. Zagari RM, Fuccio L, Wallander MA, Johansson S, Fiocca R, Casanova
S, Farahmand BY, Winchester CC, Roda E, Bazzoli F: Gastro-
oesophageal reflux symptoms, oesophagitis and Barrett's
oesophagus in the general population: Loiano-Monghidoro
study.  Gut 2008.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-230X/8/37/pre
pub